Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/182319
Share/Export:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Title

Identification of "Preferred" Human Kinase Inhibitors for Sleeping Sickness Lead Discovery. Are Some Kinases Better than Others for Inhibitor Repurposing?

AuthorsAmata, Emanuele; Xi, Hualin; Colmenarejo, Gonzalo; Díaz-González, Rosario; Cordon-Obras, Carlos; Berlanga, M.; Manzano, Pilar; Erath, Jessey; Roncal, Norma E.; Lee, Patricia J.; Leed, Susan E.; Rodríguez López, Ana CSIC ORCID; Sciotti, Richard J.; Navarro, M.; Pollastri, M.P.
KeywordsPreferred lead repurposing
Trypanosoma brucei
Trypanosoma cruzi
Leishmania major
Plasmodium falciparum
Published Kinase Inhibitor Set
Issue DateMar-2016
PublisherAmerican Chemical Society
CitationACS Infectious Diseases
AbstractA kinase-targeting cell-based high-throughput screen (HTS) against Trypanosoma brucei was recently reported, and this screening set included the Published Kinase Inhibitor Set (PKIS). From the PKIS was identified 53 compounds with pEC(50) >= 6. Utilizing the published data available for the PKIS, a statistical analysis of these active antiparasitic compounds was performed, allowing identification of a set of human kinases having inhibitors that show a high likelihood for blocking T. brucei cellular proliferation in vitro. This observation was confirmed by testing other established inhibitors of these human kinases and by mining past screening campaigns at GlaxoSmithKline. Overall, although the parasite targets of action are not known, inhibitors of this set of human kinases displayed an enhanced hit rate relative to a random kinase-targeting HTS campaign, suggesting that repurposing efforts should focus primarily on inhibitors of these specific human kinases. We therefore term this statistical analysis-driven approach "preferred lead repurposing".
URIhttp://hdl.handle.net/10261/182319
DOI10.1021/acsinfecdis.5b00136
E-ISSN2373-8227
Appears in Collections:(IPBLN) Artículos

Files in This Item:
File Description SizeFormat
accesoRestringido.pdf15,35 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work

PubMed Central
Citations

12
checked on Apr 20, 2022

SCOPUSTM   
Citations

25
checked on May 13, 2022

WEB OF SCIENCETM
Citations

24
checked on May 14, 2022

Page view(s)

214
checked on May 15, 2022

Download(s)

29
checked on May 15, 2022

Google ScholarTM

Check

Altmetric

Dimensions


Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.